CD82 controls CpG-dependent TLR9 signaling

被引:22
|
作者
Khan, Nida S. [1 ,2 ,5 ]
Lukason, Daniel P. [1 ,4 ]
Feliu, Marianela [1 ]
Ward, Rebecca A. [1 ]
Lord, Allison K. [1 ]
Reedy, Jennifer L. [1 ,5 ]
Ramirez-Ortiz, Zaida G. [5 ,6 ,7 ]
Tam, Jenny M. [1 ]
Kasperkovitz, Pia V. [9 ]
Negoro, Paige E. [1 ]
Vyas, Tammy D. [1 ]
Xu, Shuying [1 ]
Brinkmann, Melanie M. [10 ,11 ]
Acharaya, Mridu [12 ,13 ]
Artavanis-Tsakonas, Katerina [14 ]
Frickel, Eva-Maria [15 ]
Becker, Christine E. [8 ]
Dagher, Zeina [1 ]
Kim, You-Me [16 ]
Latz, Eicke [3 ,17 ,18 ]
Ploegh, Hidde L. [19 ]
Mansour, Michael K. [1 ,5 ]
Miranti, Cindy K. [20 ,21 ]
Levitz, Stuart M. [3 ]
Vyas, Jatin M. [1 ,5 ]
机构
[1] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA
[2] Univ Massachusetts Med Sch, Biomed Engn & Biotechnol, Boston, MA USA
[3] Univ Massachusetts Med Sch, Dept Med, Boston, MA USA
[4] Univ Massachusetts, Biomed Engn & Biotechnol, Lowell, MA USA
[5] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA
[6] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA
[7] Harvard Med Sch, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
[8] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02115 USA
[9] F Hoffmann La Roche Innovat Ctr Basel, Basel, Switzerland
[10] Helmholtz Ctr Infect Res, Viral Immune Modulat Res Grp, Braunschweig, Germany
[11] Tech Univ Carolo Wilhelmina Braunschweig, Inst Genet, Braunschweig, Germany
[12] Benaroya Res Inst, Seattle, WA USA
[13] Seattle Childrens Res Inst, Ctr Immun & Immunotherapy, Seattle, WA USA
[14] Univ Cambridge, Dept Pathol, Cambridge, England
[15] Francis Crick Inst, Host Toxoplasma Interact Lab, London, England
[16] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea
[17] Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, Bonn, Germany
[18] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany
[19] Boston Childrens Hosp, Boston, MA USA
[20] Van Andel Res Inst, Lab Integrin Signaling & Tumorigenesis, Grand Rapids, MI USA
[21] Univ Arizona, Canc Ctr, Dept Cellular & Mol Med, Tucson, AZ USA
来源
FASEB JOURNAL | 2019年 / 33卷 / 11期
基金
英国医学研究理事会; 英国惠康基金; 美国国家卫生研究院;
关键词
tetraspanins; TLRs; myddosome; macrophages; RECEPTOR; 9; PROTEOLYTIC CLEAVAGE; ANTIGEN PRESENTATION; INNATE IMMUNITY; DECTIN-1; ACTIVATION; PROTEIN; TRAFFICKING; INDUCTION; PATHWAY;
D O I
10.1096/fj.201901547R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tetraspanin CD82 is a potent suppressor of tumor metastasis and regulates several processes including signal transduction, cell adhesion, motility, and aggregation. However, the mechanisms by which CD82 participates in innate immunity are unknown. We report that CD82 is a key regulator of TLR9 trafficking and signaling. TLR9 recognizes unmethylated cytosine-phosphate-guanine (CpG) motifs present in viral, bacterial, and fungal DNA. We demonstrate that TLR9 and CD82 associate in macrophages, which occurs in the endoplasmic reticulum (ER) and post-ER. Moreover, CD82 is essential for TLR9-dependent myddosome formation in response to CpG stimulation. Finally, CD82 modulates TLR9-dependent NF-kappa B nuclear translocation, which is critical for inflammatory cytokine production. To our knowledge, this is the first time a tetraspanin has been implicated as a key regulator of TLR signaling. Collectively, our study demonstrates that CD82 is a specific regulator of TLR9 signaling, which may be critical in cancer immunotherapy approaches and coordinating the innate immune response to pathogens.
引用
收藏
页码:12500 / 12514
页数:15
相关论文
共 50 条
  • [21] CpG Oligodeoxynucleotides as TLR9 Agonists Therapeutic Application in Allergy and Asthma
    Gupta, Gaurav K.
    Agrawal, Devendra K.
    BIODRUGS, 2010, 24 (04) : 225 - 235
  • [22] Cpg-ODN, a TLR9 Agonist, Aggravates Myocardial Ischemia/Reperfusion Injury by Activation of TLR9-P38 MAPK Signaling
    Xie, Liang
    He, Songqing
    Kong, Na
    Zhu, Ying
    Tang, Yi
    Li, Jianhua
    Liu, Zhengbing
    Liu, Jing
    Gong, Jianbin
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (04) : 1389 - 1398
  • [23] TLR4 and TLR9 signaling in the developing mouse intestine
    Sodhi, Chhinder P.
    Gribar, Steve
    Richardson, Ward
    Branca, Maria
    Dubowski, Theresa
    Li, Jun
    Hackam, David J.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 84 (02) : A17 - A17
  • [24] Blocking TIR Domain Interactions in TLR9 Signaling
    Javmen, Artur
    Szmacinski, Henryk
    Lakowicz, Joseph R.
    Toshchakov, Vladimir Y.
    JOURNAL OF IMMUNOLOGY, 2018, 201 (03): : 995 - 1006
  • [25] Homeostatic effects of TLR9 signaling in experimental colitis
    Lee, Jongdae
    Rachmilewitz, Daniel
    Raz, Eyal
    INFLAMMATORY BOWEL DISEASE: GENETICS, BARRIER FUNCTION, IMMUNOLOGIC MECHANISMS, AND MICROBIAL PATHWAYS, 2006, 1072 : 351 - 355
  • [26] TLR9 Signaling Mediates Transgene Antibody Formation
    Ashley, Scott
    McMenamin, Deirdre
    Draper, Christine
    Wilson, James M.
    MOLECULAR THERAPY, 2016, 24 : S275 - S275
  • [27] TLR9 and its signaling pathway in multiple sclerosis
    Zhou, Yifan
    Fang, Ling
    Peng, Lisheng
    Qiu, Wei
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 373 : 95 - 99
  • [28] Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation
    Jurk, Marion
    Vollmer, Jorg
    BIODRUGS, 2007, 21 (06) : 387 - 401
  • [29] TLR9免疫识别CpG DNA的机制与途径
    李宁
    国外医学(分子生物学分册), 2003, (05) : 291 - 294
  • [30] Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy
    Jin, Yizhen
    Zhuang, Yuxin
    Dong, Xiaowu
    Liu, Mei
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (08) : 841 - 851